ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 582,14
-0,17%
DAX
18 002,02
-1,43%
Brent Oil
82,56
0,71%
Bitcoin
65 264,99
-2,24%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cytocom Inc (CBLI)

  7. Cytocom Inc (CBLI) Actualités

CBLI

Cytocom (CBLI)

Cytocom Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CBLI
DateHeureSourceTitreSymboleSociété
03/03/202316h47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CBLICytocom Inc
27/02/202312h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBLICytocom Inc
15/02/202315h10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CBLICytocom Inc
01/02/202322h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBLICytocom Inc
01/02/202322h10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CBLICytocom Inc
14/11/202223h53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBLICytocom Inc
06/10/202212h01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CBLICytocom Inc
23/09/202212h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CBLICytocom Inc
22/03/202212h34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CBLICytocom Inc
22/03/202200h27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBLICytocom Inc
15/02/202212h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBLICytocom Inc
30/09/202122h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBLICytocom Inc
31/08/202113h32PR Newswire (US)Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."NASDAQ:CBLICytocom Inc
16/08/202116h34PR Newswire (US)Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via WebcastNASDAQ:CBLICytocom Inc
16/08/202113h30PR Newswire (US)Cytocom, Inc. Reports Second Quarter 2021 Financial ResultsNASDAQ:CBLICytocom Inc
12/08/202122h05PR Newswire (US)Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance AgreementNASDAQ:CBLICytocom Inc
11/08/202113h30PR Newswire (US)Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business ConferenceNASDAQ:CBLICytocom Inc
10/08/202113h30PR Newswire (US)Cytocom, Inc. to Report Second Quarter 2021 Financial ResultsNASDAQ:CBLICytocom Inc
09/08/202113h30PR Newswire (US)Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19NASDAQ:CBLICytocom Inc
05/08/202113h33PR Newswire (US)Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabsNASDAQ:CBLICytocom Inc
29/07/202113h33PR Newswire (US)Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt FinancingNASDAQ:CBLICytocom Inc
06/07/202115h16PR Newswire (US)Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed MergerNASDAQ:CBLICytocom Inc
18/06/202100h37PR Newswire (US)Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Decl...NASDAQ:CBLICytocom Inc
11/06/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CBLICytocom Inc
17/02/202122h17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CBLICytocom Inc
17/02/202122h15PR Newswire (US)Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.NASDAQ:CBLICytocom Inc
22/12/202013h35PR Newswire (US)Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"NASDAQ:CBLICytocom Inc
11/11/202015h11InvestorsHub NewsWireImmune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating OfficerNASDAQ:CBLICytocom Inc
06/11/202023h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBLICytocom Inc
27/10/202018h14InvestorsHub NewsWireImmune Therapeutics, Inc. Announces Cytocom Conference CallNASDAQ:CBLICytocom Inc
 Showing the most relevant articles for your search:NASDAQ:CBLI

Dernières Valeurs Consultées

EU
DG
Vinci
EU
HO
Thales
EU
EN
Bouygues
NASDAQ
AAPL
Apple
EU
VIV
Vivendi
EU
AF
Air FranceKLM
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
EU
PX1
CAC 40
EU
ML
Michelin
NYSE
DIS
Walt Disney
EU
BN
Danone
COIN
ETHUSD
Ethereum
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés